Qi Li

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 3

Top Topics

Combination Therapy

Ejection Fraction

Patient Reported

Top Venues

Future oncology (London, England)

Cell death discovery

Cancer immunology research

This page only lists publications with an associated author ORCID identifier.

Publications

Shu-Kui Qin, Tian-Shu Liu, Jian-Ming Xu, Qi Li, Ying Cheng, Aimar Zhang, Regina Esser, Helena Chang, Jin Li
Impact of primary tumor side on clinical outcomes of first-line cetuximab plus FOLFOX-4 in RAS wild-type metastatic colorectal cancer. Future oncology (London, England) (2023)
Xuebing Jia, Jianbei Xi, Binle Tian, Yuanyuan Zhang, Zhilong Wang, Fan Wang, Zheng Li, Jiang Long, Jian-Fei Wang, Guo-Huang Fan, Qi Li
The tautomerase activity of tumor exosomal MIF promotes pancreatic cancer progression by modulating MDSC differentiation. Cancer immunology research (2023)
Xuebing Jia, Lei Li, Fan Wang, Ying Xue, Tongde Wu, Qianqian Jia, Yunhui Li, Chenming Wu, Yuping Chen, Jinhuan Wu, Yang Su, Xinshu Wang, Tao Zhuang, Xiao Dong, Jing Ling, Jian Yuan, Qi Li
DUB3/KLF4 combats tumor growth and chemoresistance in hepatocellular carcinoma. Cell death discovery 8 (1) (2022)